These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8781405)

  • 1. Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the big blue transgenic mouse.
    Cunningham ML; Hayward JJ; Shane BS; Tindall KR
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):683-6. PubMed ID: 8781405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
    Hayward JJ; Shane BS; Tindall KR; Cunningham ML
    Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
    Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
    Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen:carcinogen pair--2,6- and 2,4-diaminotoluene.
    Cunningham ML; Foley J; Maronpot RR; Matthews HB
    Toxicol Appl Pharmacol; 1991 Mar; 107(3):562-7. PubMed ID: 2000642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation as a determining factor for the carcinogenicity of chemicals: studies with mutagenic carcinogens and mutagenic noncarcinogens.
    Cunningham ML; Matthews HB
    Toxicol Lett; 1995 Dec; 82-83():9-14. PubMed ID: 8597159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of LacZ mutations in Muta Mouse can distinguish carcinogenic from non-carcinogenic analogues of diaminotoluenes and nitronaphthalenes.
    Kirkland D; Beevers C
    Mutat Res; 2006 Sep; 608(1):88-96. PubMed ID: 16797226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxazepam is mutagenic in vivo in Big Blue transgenic mice.
    Shane BS; deBoer JG; Glickman BW; Cunningham ML
    Carcinogenesis; 1999 Jul; 20(7):1315-21. PubMed ID: 10383906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
    Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
    Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of in vivo genotoxicity and short-term carcinogenicity assays using F344 gpt delta transgenic rats: in vivo mutagenicity of 2,4-diaminotoluene and 2,6-diaminotoluene structural isomers.
    Toyoda-Hokaiwado N; Inoue T; Masumura K; Hayashi H; Kawamura Y; Kurata Y; Takamune M; Yamada M; Sanada H; Umemura T; Nishikawa A; Nohmi T
    Toxicol Sci; 2010 Mar; 114(1):71-8. PubMed ID: 20026473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vivo mutagenicity and mutational spectrum at the lacI transgene recovered from the spleens of B6C3F1 lacI transgenic mice following a 4-week inhalation exposure to 1,3-butadiene.
    Recio L; Pluta LJ; Meyer KG
    Mutat Res; 1998 Jun; 401(1-2):99-110. PubMed ID: 9639685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure.
    Walker VE; Sisk SC; Upton PB; Wong BA; Recio L
    Mutat Res; 1997 Aug; 392(3):211-22. PubMed ID: 9294020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocol.
    Lefevre PA; Tinwell H; Ashby J
    Mutagenesis; 1997 Jan; 12(1):45-7. PubMed ID: 9025097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacI transgenic mice (Big Blue): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure.
    Recio L; Meyer KG; Pluta LJ; Moss OR; Saranko CJ
    Environ Mol Mutagen; 1996; 28(4):424-9. PubMed ID: 8991073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism, disposition, and mutagenicity of 2,6-diaminotoluene, a mutagenic noncarcinogen.
    Cunningham ML; Burka LT; Matthews HB
    Drug Metab Dispos; 1989; 17(6):612-7. PubMed ID: 2575496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo genotoxicity of 2-amino-3,8-dimethylimidazo[4, 5-f]quinoxaline in lacI transgenic (Big Blue) mice.
    Itoh T; Suzuki T; Nishikawa A; Furukawa F; Takahashi M; Xue W; Sofuni T; Hayashi M
    Mutat Res; 2000 Jun; 468(1):19-25. PubMed ID: 10863154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotoxic and non-genotoxic activities of 2,4- and 2,6-diaminotoluene, as evaluated in Fischer-344 rat liver.
    Taningher M; Peluso M; Parodi S; Ledda-Columbano GM; Columbano A
    Toxicology; 1995 May; 99(1-2):1-10. PubMed ID: 7761993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and genotoxic interactions of 2-aminofluorene and 2,4-diaminotoluene.
    Pan YH; Reed GA
    Toxicol Lett; 1997 Mar; 91(1):73-82. PubMed ID: 9096289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice.
    Suzuki T; Itoh T; Hayashi M; Nishikawa Y; Ikezaki S; Furukawa F; Takahashi M; Sofuni T
    Environ Mol Mutagen; 1996; 28(4):348-53. PubMed ID: 8991063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.